Pharmaceutical and Medical Device
King & Spalding’s Pharmaceutical & Medical Device practice is consistently recognized as among the best in the nation. Our knowledge of the industry, combined with our broad capabilities and a deep bench of first-chair trial attorneys, allow us to handle any aspect of drug and device litigation, from early case assessment, through discovery, and on to trial and exit strategies.
September 4, 2024
Transitional Coverage for Emerging Technologies: CMS’s Latest, But Not Necessarily Greatest, Coverage with Evidence Approach
August 23, 2024
Predetermined Change Control Plans (PCCPs) for Medical Devices: FDA Issues Draft Guidance
August 8, 2024
DOJ Announces Corporate Whistleblower Awards Pilot Program
September 11, 2024
Four-Partner Team Led by Renowned Trial Lawyer Kim Bueno Joins King & Spalding’s Product Liability and Mass Torts Practice
August 12, 2024
M&A partner Joseph Halloum joins the firm’s Corporate practice group and Technology industry team in Silicon Valley
August 27, 2024
King & Spalding Secures Summary Judgment Wins for Merck and Organon in Nationwide Litigation